Claudia Agabiti Rosei Selected Research

Claudia Agabiti Rosei Research Topics

3	Hypertension (High Blood Pressure) 03/2022 - 01/2017
3	Essential Hypertension 01/2018 - 04/2010
1	Hypercholesterolemia 03/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2022
1	Hypertensive Crisis 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Cardiomegaly (Heart Hypertrophy) 01/2018
1	Heart Failure 06/2017
1	Vascular System Injuries 01/2017
1	Inflammation (Inflammations) 01/2017
1	Mood Disorders (Mood Disorder) 03/2016
1	Familial Amyloidosis (Hereditary Amyloidosis) 01/2015
1	Amyloidosis 01/2015
1	Type 2 Diabetes Mellitus (MODY) 10/2014
1	Pheochromocytoma 06/2008
1	Pneumoperitoneum 06/2008
1	Neoplasms (Cancer) 06/2008

2	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 01/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018 - 10/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022
1	LDL CholesterolIBA 03/2022
1	Bile Acids and Salts (Bile Acids)IBA 03/2022
1	Ezetimibe (Zetia)FDA Link 03/2022
1	elastin microfibril interface located protein (emilin)IBA 01/2018
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018
1	DiureticsIBA 01/2018
1	Fibronectins (Fibronectin)IBA 01/2018
1	Laminin (Merosin)IBA 01/2018
1	Angiotensin Receptor AntagonistsIBA 01/2018
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 10/2017
1	Enalapril FDA LinkGeneric 10/2017
1	lercanidipineIBA 10/2017
1	Angiotensin IIIBA 01/2017
1	SaltsIBA 03/2016
1	Pharmaceutical PreparationsIBA 03/2016
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2015
1	Retinaldehyde (Retinal)IBA 10/2014
1	aliskiren FDA Link 10/2014
1	Ramipril (Altace)FDA LinkGeneric 10/2014
1	Ethanol (Ethyl Alcohol)IBA 04/2010
1	FlavonoidsIBA 04/2010
1	Vasodilator Agents (Vasodilators)IBA 04/2010
1	CatecholaminesIBA 06/2008